Overexpression of IL-1ra gene up-regulates interleukin-1β converting enzyme (ICE) gene expression: possible mechanism underlying IL-1β-resistance of cancer cells

[1]  E. Thiel,et al.  Autocrine interleukin‐1 receptor antagonist can support malignant growth of glioblastoma by blocking growth‐inhibiting autocrine loop of interleukin‐1 , 1997, International journal of cancer.

[2]  M. Tocci,et al.  IL-1 beta convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms. , 1997, Journal of immunology.

[3]  J. Mountz,et al.  Intracellular IL-1beta is an inhibitor of Fas-mediated apoptosis. , 1996, Journal of immunology.

[4]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[5]  Junying Yuan,et al.  Functional role of interleukin 1 beta (IL-1 beta) in IL-1 beta- converting enzyme-mediated apoptosis , 1996, The Journal of experimental medicine.

[6]  A. Fauci,et al.  Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. , 1996, Journal of immunology.

[7]  S. Nagata,et al.  Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis , 1996, Nature.

[8]  C. Dinarello,et al.  Biologic basis for interleukin-1 in disease. , 1996, Blood.

[9]  Y. Kanegae,et al.  Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Sugano,et al.  Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. , 1995, Nucleic acids research.

[11]  M. Miura,et al.  Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[12]  T. Nishi,et al.  Autocrine Growth of Transitional Cell Carcinoma of the Bladder Induced by Granulocyte-Colony Stimulating Factor 1 , 2006 .

[13]  P. Ghezzi,et al.  Autocrine interleukin-1 beta regulates both proliferation and apoptosis in EL4-6.1 thymoma cells. , 1995, Blood.

[14]  A. Rubartelli,et al.  Synthesis and Secretion of Interleukin-1α and Intedeukin-1 Receptor Antagonist during Differentiation of Cultured Keratinocytes , 1995 .

[15]  Y. Furukawa,et al.  Preferential Production of Interleukin‐1β over Interleukin‐1 Receptor Antagonist Contributes to Proliferation and Suppression of Apoptosis in Leukemic Cells , 1995, Japanese journal of cancer research : Gann.

[16]  P. Sansonetti,et al.  Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri. , 1994, The Journal of clinical investigation.

[17]  Y. Kanegae,et al.  A simple and efficient method for purification of infectious recombinant adenovirus. , 1994, Japanese journal of medical science & biology.

[18]  H. Hayashi,et al.  Resistance to the anti‐proliferative effect of IL‐1 on human melanoma cell line is associated with endogenous production of IL‐1 and IL‐6 , 1994, International journal of cancer.

[19]  Junying Yuan,et al.  Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 , 1993, Cell.

[20]  Shai Shaham,et al.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.

[21]  H. Yokozaki,et al.  Interleukin 1α Acts as an Autocrine Growth Stimulator for Human Gastric Carcinoma Cells , 1993 .

[22]  C. Dinarello,et al.  The role of interleukin-1 in disease. , 1993, The New England journal of medicine.

[23]  C. March,et al.  Molecular cloning of the interleukin-1 beta converting enzyme. , 1992, Science.

[24]  R. Thompson,et al.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. , 1991, Immunology today.

[25]  E. Unanue,et al.  Interleukin 1 is processed and released during apoptosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Grassi,et al.  Determination of ILlα, ILlβ and IL2 in Biological Media using Specific Enzyme Immunometric Assays , 1991, Immunological reviews.

[27]  D. Roeder,et al.  Extension of the life-span of human endothelial cells by an interleukin-1 alpha antisense oligomer. , 1990, Science.

[28]  R. Thompson,et al.  Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. , 1990, The Journal of clinical investigation.

[29]  J. Meer,et al.  Differences in the synthesis and kinetics of release of interleukin 1α, interleukin 1β and tumor necrosis factor from human mononuclear cells , 1989, European journal of immunology.

[30]  P. Cameron,et al.  Identification of a monocyte specific pre-interleukin 1 beta convertase activity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Black,et al.  Activation of interleukin‐ 1β by a co‐induced protease , 1989 .

[32]  G. Freeman,et al.  Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation. , 1988, Journal of immunology.

[33]  D. Hazuda,et al.  The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. , 1988, The Journal of biological chemistry.

[34]  C. Dinarello,et al.  Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line. , 1987, Journal of immunology.

[35]  C. Avnstorp,et al.  Interleukin‐1 , 1987 .

[36]  E. Gaffney,et al.  Lymphocyte-activating and growth-inhibitory activities for several sources of native and recombinant interleukin 1. , 1986, Cancer research.

[37]  K. Matsushima,et al.  There is more than one interleukin 1. , 1986, Immunology today.

[38]  B. Aggarwal,et al.  Human interleukin 1 is a cytocidal factor for several tumor cell lines. , 1985, Journal of immunology.

[39]  M. Tachibana.  Studies on cellular adhesiveness in five different culture cell lines derived from carcinoma of the urinary bladder. , 1982, The Keio journal of medicine.

[40]  S. Mizel,et al.  Interleukin 1, a potential regulator of fibroblast proliferation. , 1982, Journal of immunology.

[41]  S. Baba,et al.  Transplantation of human renal cell carcinoma to the nude mice: as an intermediate of in vivo and in vitro studies. , 1976, The Journal of urology.

[42]  I. Gery,et al.  POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS , 1972, The Journal of experimental medicine.

[43]  P. Ghezzi,et al.  Autocrine Interleukin-lp Regulates Both Proliferation and Apoptosis in EL 4-6 . 1 Thymoma Cells , 2000 .

[44]  M. Murai,et al.  Constitutive production of multiple cytokines and a human chorionic gonadotrophin beta-subunit by a human bladder cancer cell line (KU-19-19): possible demonstration of totipotential differentiation. , 1997, British Journal of Cancer.

[45]  A. Uchida,et al.  Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder. , 1997, British Journal of Cancer.

[46]  R. Black,et al.  Activation of interleukin-1 beta by a co-induced protease. , 1989, FEBS letters.